Page 47 - Contract Development News Today

/PRNewswire/ -- Viralgen Vector Core (Viralgen), an independently operated subsidiary of Asklepios BioPharmaceutical, Inc. (AskBio), and a member of the Bayer...

/PRNewswire/ -- The "Pharmaceutical & Biopharmaceutical Contract Manufacturing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast,...

23 Life Sciences Trends to Watch for in 2023

Stelis Biopharma Ltd has announced that its CDMO partner has received approval for a key ANDA from the United States Food & Drug Administration.

Reliance Retail has become India's biggest brick-and-mortar retailer with over 16,600 stores. It is ranked 56th amongst the top global retailers with $18 billion in revenues and is the world's second-fastest-growing retail company behind only South Korea's Coupang.

Cement, retail, pharmaceuticals and quick commerce were the sectors that witnessed multi-crore deals as players sought to enhance their respective positions in the industry. Get more Economy & Infra News and Business News on Zee Business.

NEW DELHI, Dec 30: As India remained a bright spot in an otherwise gloomy global economic scenario, the country’s corporate sector showed a good appetite for acquisitions in 2022, a year which also saw the downfall of some of its prominent leaders. Cement, retail, pharmaceuticals and quick commerce were the sectors that witnessed multi-crore deals as players sought to enhance their respective positions in the industry. India Inc also lost two of its leaders — former Tata Sons chairma...

Global private equity (PE) investor Advent International on Monday said it is acquiring a significant stake in Suven Pharmaceuticals from its promoters, the Jasti family.

Mumbai, Dec 26: Global private equity investor Advent International on Monday said it is acquiring a significant stake in Suven Pharmaceuticals from its promoters, the Jasti family. The PE major said this will be followed with an open offer to acquire 26 per cent more in the listed contract development and manufacturing organisation from public shareholders, and also merge the company with investee company Cohance Lifesciences, as per an official statement. Media reports on a Monday morning pegg...

An Open Offer is being made for acquisition of up to 6,61,86,889 fully paid-up equity shares of face value of INR 1 each representing 26.00% of the Voting Share Capital of Suven Pharmaceuticals Ltd at a price of Rs. 495 per share.